医学
社会心理的
乳腺癌
应对(心理学)
生物心理社会模型
苦恼
数据提取
斯科普斯
系统回顾
梅德林
临床心理学
癌症
精神科
内科学
政治学
法学
作者
Majid Omari,Btissame Zarrouq,Lamiae Amaadour,Zineb Benbrahim,Achraf El Asri,Nawfel Mellas,Karima El Rhazi,Mohammed El Amine Ragala,Karima Halim
出处
期刊:Cancer Control
[SAGE]
日期:2022-01-01
卷期号:29: 107327482210747-107327482210747
被引量:14
标识
DOI:10.1177/10732748221074735
摘要
Women with breast cancer eligible for neoadjuvant therapy (NAT) present a disorder of biopsychosocial variables and alteration of their quality of life. They cope with this changing by adopting psychological adjustment strategies, either passive or active. This systematic review aims to investigate the psychological distress, coping strategies, and quality of life in breast cancer patients under neoadjuvant therapy.Cochrane Library, PubMed, ScienceDirect, Scopus, Web of Science, and Wiley Online library represent the databases that were searched to identify relevant published articles until September 27, 2021. Full-text published articles, written in English and assessing the main outcomes (namely: psychological distress, coping strategies, and quality of life) in women with breast cancer under NAT will be included. Also, we will integrate papers dealing with the related bio psychosocial variables to the main variables. The paper selection, data extraction, and quality assessment of selected studies will be performed independently by two researchers, and disagreements will be resolved through discussions. We will bring together the results of all of the included studies to draw conclusions based on the body of evidence. The narrative approach will be adopted to analyze the results and conclusions extracted and we would perform quantitative groupings if we have similar data.Ethical approval is not required as the proposed systematic review will not use primary data. The results of this review will be disseminated through publication in a peer-reviewed journal and conference presentation(s). PROSPERO registration number: CRD42021230300.
科研通智能强力驱动
Strongly Powered by AbleSci AI